This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors | MicrobiomeTrials
← Back to trials NCT03739827
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2019-01-28Est. Completion: 2028-05-31
Enrollment target: 10,000 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Oregon Health and Science University, Portland, Oregon, United States Texas Children's Hospital, Houston, Texas, United States Other microbiome trials you might be interested in Endometrial Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Dedifferentiated Carcinoma Endometrial Endometrioid Adenocarcinoma Endometrial Mixed Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Endometrial Undifferentiated Carcinoma Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, t…
Birmingham, United States Est. completion Oct 31, 2027
Metastatic Lung Small Cell Carcinoma Metastatic Malignant Solid Neoplasm Metastatic Neuroendocrine Carcinoma Metastatic Pancreatic Adenocarcinoma Stage III Lung Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Lung Small Cell Carcinoma Unresectable Malignant Solid Neoplasm Unresectable Neuroendocrine Carcinoma Unresectable Pancreatic Adenocarcinoma
This phase I trial tests the safety, side effects and best dose of BAY 1895344 when given together with usual chemothera…
Phoenix, United States Est. completion Feb 15, 2025
Bladder Adenocarcinoma Bladder Clear Cell Adenocarcinoma Bladder Mixed Adenocarcinoma Bladder Neuroendocrine Carcinoma Bladder Small Cell Neuroendocrine Carcinoma Bladder Squamous Cell Carcinoma Chromophobe Renal Cell Carcinoma Collecting Duct Carcinoma Invasive Bladder Giant Cell Urothelial Carcinoma Invasive Bladder Lymphoepithelioma-Like Carcinoma Invasive Bladder Nested Urothelial Carcinoma Invasive Bladder Plasmacytoid Urothelial Carcinoma Invasive Bladder Sarcomatoid Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma Kidney Medullary Carcinoma
Large Cell Neuroendocrine Carcinoma
Malignant Testicular Leydig Cell Tumor
Malignant Testicular Sertoli Cell Tumor
Metastatic Bladder Carcinoma
Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma
Metastatic Bladder Giant Cell Urothelial Carcinoma
Metastatic Bladder Large Cell Neuroendocrine Carcinoma
Metastatic Bladder Lipid-Rich Urothelial Carcinoma
Metastatic Bladder Micropapillary Urothelial Carcinoma
Metastatic Bladder Plasmacytoid Urothelial Carcinoma
Metastatic Bladder Sarcomatoid Urothelial Carcinoma
Metastatic Bladder Small Cell Neuroendocrine Carcinoma
Metastatic Bladder Squamous Cell Carcinoma
Metastatic Chromophobe Renal Cell Carcinoma
Metastatic Kidney Medullary Carcinoma
Metastatic Malignant Genitourinary System Neoplasm
Metastatic Papillary Renal Cell Carcinoma
Metastatic Penile Carcinoma
Metastatic Prostate Small Cell Neuroendocrine Carcinoma
Metastatic Sarcomatoid Renal Cell Carcinoma
Metastatic Urethral Carcinoma
Papillary Renal Cell Carcinoma
Sarcomatoid Renal Cell Carcinoma
Stage IV Bladder Cancer AJCC v8
Stage IV Penile Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Stage IV Urethral Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8
Urachal Adenocarcinoma
Urethral Clear Cell Adenocarcinoma
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patient…
Birmingham, United States Est. completion Feb 28, 2027